Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 9,900 shares at $10.44 ($105K) on 2007-09-19, disclosed to the SEC on 2007-09-20.
Scheduled sale ($105k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.39 | 100 | $1K | 1.0% |
| 2 | $10.40 | 300 | $3K | 3.0% |
| 3 | $10.42 | 300 | $3K | 3.0% |
| 4 | $10.44 | 400 | $4K | 4.0% |
| 5 | $10.45 | 300 | $3K | 3.0% |
| 6 | $10.46 | 500 |
| $5K |
| 5.0% |
| 7 | $10.47 | 900 | $9K | 9.0% |
| 8 | $10.48 | 300 | $3K | 3.0% |
| 9 | $10.49 | 300 | $3K | 3.0% |
| 10 | $10.50 | 100 | $1K | 1.0% |
| 11 | $10.51 | 400 | $4K | 4.0% |
| 12 | $10.52 | 200 | $2K | 2.0% |
| 13 | $10.53 | 300 | $3K | 3.0% |
| 14 | $10.56 | 100 | $1K | 1.0% |
| 15 | $10.57 | 300 | $3K | 3.0% |
| 16 | $10.59 | 700 | $7K | 7.1% |
| 17 | $10.60 | 800 | $8K | 8.1% |
| 18 | $10.61 | 300 | $3K | 3.0% |
| 19 | $10.62 | 300 | $3K | 3.0% |
| 20 | $10.63 | 500 | $5K | 5.1% |
| 21 | $10.63 | 100 | $1K | 1.0% |
| 22 | $10.64 | 100 | $1K | 1.0% |
| 23 | $10.65 | 500 | $5K | 5.1% |
| 24 | $10.66 | 200 | $2K | 2.0% |
| 25 | $10.66 | 400 | $4K | 4.1% |
| 26 | $10.67 | 100 | $1K | 1.0% |
| 27 | $10.68 | 800 | $9K | 8.2% |
| 28 | $10.69 | 300 | $3K | 3.1% |
| Total | $10.56 avg | 9,900 | $105K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |